The Latest Cardiac and Vascular News
HANGZHOU, China, March 7, 2024 /PRNewswire/ — Zylox-Tonbridge (2190.HK, “the Company”), a leading medical device company in the peripheral and neurovascular interventional market in China, today announced a new strategic partnership with Avinger, a commercial-stage medical device company…
Unique new dual-lumen catheter enables safer, more cost-effective transeptal crossing and left atrial access, improving cardiologist and patient experience; CRT “Best Interesting Case” highlights left appendage closure device implantation without the need for TEE or anesthesia SCOTTSDALE, Ariz., March 5, 2024 /PRNewswire/ — Franklin Mountain Medical announced today that the Dib UltraNav Transseptal […]
LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Oppenheimer 34th Annual Virtual Healt
LA JOLLA, Calif.–(BUSINESS WIRE)–La Jolla Vein & Vascular, a leading provider of vascular health services in the San Diego area, is excited to announce their upcoming event today, the World Lymphedema Day Patient Education Event. This informative and educational function is scheduled to take place on March 6, 2024, in the practice lobby of La Jolla Vein & Vascular. Lymphedema, a condition affecting many individuals around the world, is a chronic disorder that can have a significant im
Southlake, TX, March 06, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that the Canadian Intellectual Property Office Application […]
– Record fourth quarter 2023 CGuard EPS revenue of $1.76 million increased 71.6% over fourth quarter 2022 – – Announced positive 30-day data from the Company’s ongoing U.S. Investigational Device Exemption (IDE) clinical trial, C-GUARDIANS, designed to support U.S. approval of CGuard Prime – – Named Patrick Geraghty, M.D. and […]
LONDON–(BUSINESS WIRE)– #cardiacsurgery–LivaNova announced the pricing of $300 million aggregate principal amount of 2.50% convertible senior notes due 2029 issued in a private offering.
SOUTH JORDAN, Utah, March 05, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today a series of events for clinicians attending the 2024 SIR Annual Meeting. These educational events will take place at Merit’s headquarters and at SIR booth 320. On […]
DENVER–(BUSINESS WIRE)–Cleerly, the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its Coronary Artery Disease (CAD) Staging System. The CAD Staging System is a […]
CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announces that the U.S. Patent and Trademark Office has issued a notice of allowance to University of Iowa Research Foundation (“UIRF”) for U.S. Application No. 17,857,723 titled Compositions and Methods for Detecting Predisposition to Cardiovascular Disease, which is […]
